Search Results - "Tiriac, H."

Patient‐derived organoid models help define personalized management of gastrointestinal cancer by Aberle, M. R., Burkhart, R. A., Tiriac, H., Olde Damink, S. W. M., Dejong, C. H. C., Tuveson, D. A., van Dam, R. M.

“…Background The prognosis of patients with different gastrointestinal cancers varies widely. Despite advances in treatment strategies, such as extensive…”
Get full text

194 Pancreatic ductal organoids as a new platform for drug discovery by Ponz-Sarvise, M, Corbo, V, Öhlund, D, Oni, T, Handly-Santana, A, Engle, D, Tiriac, H, Chio, C, Feigin, M, Baker, L, Ardito-Abraham, C, Park, Y, Hwang, C, Elyada, E, Yu, K, Clevers, H, Tuveson, D.A

Get full text

Synergism between SUMO inhibition and irreversible electroporation for pancreatic cancer by de la Torre, J., Narayanan, J Shankara, Tiriac, H., Nolan, N., Chen, Y., White, R.

Get full text

Dual Inhibition of KRASG12D and Pan-ERBB Is Synergistic in Pancreatic Ductal Adenocarcinoma by Gulay, Kevin Christian Montecillo, Zhang, Xinlian, Pantazopoulou, Vasiliki, Patel, Jay, Esparza, Edgar, Pran Babu, Deepa Sheik, Ogawa, Satoshi, Weitz, Jonathan, Ng, Isabella, Mose, Evangeline S, Pu, Minya, Engle, Dannielle D, Lowy, Andrew M, Tiriac, Hervé

“…Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer with a low survival rate. Recently, new drugs that target KRASG12D, a common mutation in PDAC, have…”
Get full text

Using mouse and human pancreatic organoids to infer resistance to targeted therapy by Ponz-Sarvise, M., Corbo, V., Frese, K., Tiriac, H., Engle, D., Filipini, D., Wright, K., Park, Y., Yu, K., Daniel, Ö, Tuveson, D.

Get full text